FDA Approves ImClone Cancer Drug

The Food and Drug Administration approves Erbitux, a colon cancer drug made by ImClone. The drug is at the center of the insider-trading trial of Martha Stewart. Stewart's sale of shares in the company occurred shortly after ImClone received a letter from the FDA saying Erbitux would not be approved. NPR's Snigdha Prakash reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: